Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

BioNexus Gene Lab (BGLC) Times Interest Earned (2021 - 2025)

BioNexus Gene Lab's Times Interest Earned history spans 5 years, with the latest figure at -$315.66 for Q4 2025.

  • Quarterly results put Times Interest Earned at -$315.66 for Q4 2025, down 340.78% from a year ago — trailing twelve months through Dec 2025 was -$151.73 (down 103.88% YoY), and the annual figure for FY2025 was -$151.73, down 103.88%.
  • Times Interest Earned for Q4 2025 was -$315.66 at BioNexus Gene Lab, down from -$108.38 in the prior quarter.
  • In the past five years, Times Interest Earned ranged from a high of $89.48 in Q2 2023 to a low of -$593.69 in Q3 2023.
  • The 5-year median for Times Interest Earned is -$50.44 (2021), against an average of -$79.94.
  • Peak annual rise in Times Interest Earned hit 250.41% in 2023, while the deepest fall reached 1986.25% in 2023.
  • Year by year, Times Interest Earned stood at -$50.44 in 2021, then surged by 151.08% to $25.76 in 2022, then skyrocketed by 139.17% to $61.62 in 2023, then crashed by 216.22% to -$71.61 in 2024, then tumbled by 340.78% to -$315.66 in 2025.
  • According to Business Quant data, Times Interest Earned over the past three periods came in at -$315.66, -$108.38, and -$125.29 for Q4 2025, Q3 2025, and Q2 2025 respectively.